Paulo Henrique Evangelista-Silva

Dr. Paulo Henrique Evangelista-Silva

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2023 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
LMLauane Gomes Moreno
Lauane Gomes Moreno
NCNayara Rayane César
Nayara Rayane César
DMDirceu Sousa Melo
Dirceu Sousa Melo
MFMaria Thereza Otoni Figueiró
Maria Thereza Otoni Figueiró
ESEdivânia Cordeiro dos Santos
Edivânia Cordeiro dos Santos
ELIZABETHE ADRIANA ESTEVESELIZABETHE ADRIANA ESTEVES
ELIZABETHE ADRIANA ESTEVES

8 June 2021 in European Journal of Lipid Science and Technology
Verified
Journal Article
Closed access
PDF file
LMLauane G. Moreno
Lauane G. Moreno
Paulo Henrique Evangelista-SilvaPaulo Henrique Evangelista-Silva
Paulo Henrique Evangelista-Silva
ESEdivânia C. Santos
Edivânia C. Santos
RPRodrigo P. Prates
Rodrigo P. Prates
ALArtenizia C. Lima
Artenizia C. Lima
ELIZABETHE ADRIANA ESTEVESELIZABETHE ADRIANA ESTEVES
ELIZABETHE ADRIANA ESTEVES

1 December 2020 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
MRManuela Ortega Marques Rodrigues
Manuela Ortega Marques Rodrigues
Paulo Henrique Evangelista-SilvaPaulo Henrique Evangelista-Silva
Paulo Henrique Evangelista-Silva
NNNilma Nayara Neves
Nilma Nayara Neves
LMLauane Gomes Moreno
Lauane Gomes Moreno
CSCarina Sousa Santos
Carina Sousa Santos
EEElizabethe Adriana Esteves
Elizabethe Adriana Esteves
Caloric restriction (CR) reduces body weight and systemic inflammation, but the effects on adipose tissue under dietary lipid overload are controversial. We evaluated the effects of CR-induced weight loss with a high-fat diet on adipose tissue inflammation of obese mice. Male mice were assigned into low-fat diet (LF) and high-fat diet (HF) groups. After 8 weeks, the mice in the HF group were reassigned for another 7 weeks into the following 3 conditions: (i) kept in the HF condition; (ii) changed to low-fat diet ad libitum (LFAL); and (iii) changed to high-fat calorie-restricted (RHF) diet to reach LFAL body weight. Serum markers, adipocytokines, morphology, and inflammatory infiltrates in retroperitoneal adipose tissue (RAT) were accessed. The body weights of the LFAL and RHF groups were reduced, equaling the body weights of the LF group. The LFAL mice had restored almost all inflammatory markers as the LF mice, except tumor necrosis factor-alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1), and adiponectin. Compared with the HF group, the RHF group had lowered visceral adiposity, retroperitoneal adipocyte sizes, and RAT inflammatory cell infiltration, as well as TNF-α, interleukin-6, and hepatic and serum C-reactive protein, which were higher than that of the LFAL group; adiponectin and MCP-1 did not change. CR with high-fat diet reduced body weight and attenuated visceral adiposity but did not fully recover visceral tissue inflammation. Novelty Caloric restriction in a high-fat diet ameliorated visceral adiposity. Caloric restriction in a high-fat diet did not recover visceral adipose tissue inflammation.

8 February 2017 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
LOLidiane Guedes Oliveira
Lidiane Guedes Oliveira
LMLauane Gomes Moreno
Lauane Gomes Moreno
DMDirceu Sousa Melo
Dirceu Sousa Melo
LCLiliane Vanessa Costa-Pereira
Liliane Vanessa Costa-Pereira
MCMayara Medeiros de Freitas Carvalho
Mayara Medeiros de Freitas Carvalho
EEElizabethe Adriana Esteves
Elizabethe Adriana Esteves
Caryocar brasiliense (pequi) oil is high in monounsaturated fat acids (MUFA), especially oleic, and in carotenoids, which have been associated with protection against cardiovascular disease. However, this food is poorly studied in this context, especially in the cardiac function. Therefore, we investigated the effects of a long-term intake of pequi oil in systemic cardiovascular risk factors and in the ex vivo cardiac function of rats. Previously, we determined fatty acids and carotenoids in pequi oil. Next, male rats were divided in C – control group feed a standard diet, and PO – pequi oil group fed the same diet added pequi oil (+2.25 g.100 g−1). After 15 weeks, plasma lipids, glucose, insulin, blood pressure, heart rate, hepatic lipids were accessed and visceral fat pads were harvested. Hearts were used for the ex vivo cardiac function, histologic assays, SERCA2a and phospholanban (PLB) determinations. In agreement with scientific data, pequi oil had expressive amounts MUFA, especially oleic acid, and carotenoids. Hepatic triglycerides (TG) were reduced by pequi oil intake (p < 0.05). All others cardiovascular risk factors were not changed. The intrinsic heart rate was lower in PO group (p < 0.05). SERCA2a content was higher in this group (p < 0.05), without affecting PLB. Also, SERCA2a/PLB ratio increased in PO group (p < 0.05). Pequi oil intake improved cardiac function ex vivo, despite no significant changes in systemic cardiovascular risk factors. The higher lipid offer in pequi oil diet, its composition in oleic acid and carotenoids could be related to those effects.

1 August 2021 in Life Sciences
Verified
Journal Article
Closed access
Paulo Henrique Evangelista-SilvaPaulo Henrique Evangelista-Silva
Paulo Henrique Evangelista-Silva
RPRodrigo Pereira Prates
Rodrigo Pereira Prates
JLJaqueline Santos Moreira Leite
Jaqueline Santos Moreira Leite
LMLauane Gomes Moreno
Lauane Gomes Moreno
FGFrancemilson Goulart-Silva
Francemilson Goulart-Silva
ELIZABETHE ADRIANA ESTEVESELIZABETHE ADRIANA ESTEVES
ELIZABETHE ADRIANA ESTEVES

22 January 2025 in Molecular Metabolism
Verified
Journal Article
Open access
ESEya Sellami
Eya Sellami
Paulo Henrique Evangelista-SilvaPaulo Henrique Evangelista-Silva
Paulo Henrique Evangelista-Silva
CTCaio Jordão Teixeira
Caio Jordão Teixeira
KDKhoudia Diop
Khoudia Diop
PMPatricia Mitchell
Patricia Mitchell
FAFernando Forato Anhê
Fernando Forato Anhê
Increased fructose consumption contributes to type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), but the mechanisms are ill-defined. Gut nutrient sensing involves enterohormones like Glucagon-like peptide (Glp)2, which regulates the absorptive capacity of luminal nutrients. While glucose is the primary dietary energy source absorbed in the gut, it is unknown whether excess fructose alters gut glucose sensing to impair blood glucose regulation and liver homeostasis. Mice were fed diets where carbohydrates were either entirely glucose (70 %Kcal) or glucose partially replaced with fructose (8.5 %Kcal). Glp2 receptor (Glp2r) was inhibited with Glp2 (3-33) injections. Glucose tolerance, insulin sensitivity, and gut glucose absorption were concomitantly assessed, and enteric sugar transporters and absorptive surface were quantified by RT-qPCR and histological analysis, respectively. High fructose feeding led to impairment of blood glucose disposal, ectopic fat accumulation in the liver, and hepatic (but not muscle or adipose tissue) insulin resistance independent of changes in fat mass. This was accompanied by increased gut glucose absorption, which preceded glucose intolerance and liver steatosis. Fructose upregulated glucose transporters and enlarged the gut surface, but these effects were prevented by Glp2r inhibition. Blocking Glp2r prevented fructose-induced impairments in glucose disposal and hepatic lipid handling. Excess fructose impairs blood glucose and liver homeostasis by rewiring gut glucose sensing and exacerbating gut glucose absorption. Our findings are positioned to inform novel early diagnostic tools and treatments tailored to counter high fructose-induced metabolic derangements predisposing to T2D and MASLD.